in patients with primary hyperlipoproteinemia ( 23 patients type ii a and ii b , 13 patients type iv ) , changes in lipoprotein concentrations ( lipid fraction ) , fibrinogen concentrations , in kinematic serum and plasma viscosity ( determined by means of a capillary viscosimeter ) and changes in relative apparent viscosity at shear rate 46 s-1 and 115 s-1 ( determined by means of a plate-cone-viscosimeter ) were measured before and after a clofibrate therapy ( 2 x 1 g/day ) lasting for 7 to 9 weeks .
C0020476
hyperlipoproteinemia
C0009002
clofibrate